Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page
- Haemophilus influenzae type B vaccine, and antigen-specific antibody responses in SLE, 1828
- Hamster models, joint disuse and cartilage degeneration, 2068
- Hand
- CREST in, 373
- median nerve compression, 720
- in OA, hemiparalysis impact on expression of, 2249
- Heart block, maternal autoantibodies and fetal, 2079
- Heat-shock proteins, Yersinia antigen, 855
- Hemochromatosis, radiographic presentation of, 1325
- Hemiparalysis, impact on expression of OA, 2249
- Hemostasis, and anticardiolipin antibodies, 1420
- Henoch-Schonlein purpura, in adulthood and childhood, 1518
- Heparan sulfate proteoglycan, in rheumatoid synovitis, 1365
- Hepatitis C virus
- arthralgia and cryoglobulinemia in HIV and, 740
- autoantibodies in HIV, with and without concurrent, 2077
- inflammatory myopathy and, 1323
- Heterotopic ossification, in critically ill patients, 1329
- Hip, camptodactyly-arthropathy-coxa vara pericarditis in, 730
- Hip OA
- avocado/soybean unsaponifiables efficacy in, 81
- prevalence estimates by three radiographic scoring systems, 361
- prevention update, 1343
- and vitamin D receptor, COL1A1, and COL2A1 genes in postmenopausal women, 1946
- Histidinohydroxylsinonorleucine, in skin in SSc, 376
- Histiocytes, and fibroblastic rheumatism, 379
- Histone H1, autoantibodies, and LE cells, 1446
- HLA class I, and pauciarticular-onset JRA, 1620
- HLA class II
- genes and Ro/SSA and La/SSB, 927
- pauciarticular-onset JRA and, 1620
- Ro/SSA and La/SSB and, 927
- tumor necrosis factor alleles in anti-topoisomerase I responders in SSc and, 1306
- HLA phenotype, systemic sclerosis-rheumatoid arthritis syndrome, 757, 758
- HLA-B27
- in ankylosing spondylitis, and tumor necrosis factor α, 1489
- -associated spondylarthritis, juvenile, drug-induced pancytopenia in, 1899
- associations in poststreptococcal ReA, 1096
- pauciarticular-onset JRA and, 1620
- in spondylarthropathy, and positive and negative blood donors, 58
- spondylarthropathy and, 68, 949
- HLA-B35, and pauciarticular-onset JRA, 1620
- HLA-B51, association with Behcet's disease, 68
- HLA-B60, in RA, 498
- HLA-Cw3, in RA, 498
- HLA-DMA, in RA, 946, 947
- HLA-DMB, in RA, 946, 947
- HLA-DQ, alleles, 68
- HLA-DQA1, in familial idiopathic inflammatory myopathy, 710
- HLA-DR, in ankylosing spondylitis, 460
- HLA-DR4, and pauciarticular-onset JRA, 1620
- HLA-DR5, and pauciarticular-onset JRA, 1620
- HLA-DR7, in SSc, 74
- HLA-DR8, and pauciarticular-onset JRA, 1620
- HLA-DR11, in SSc, 74
- HLA-DRB1, associations in poststreptococcal reactive arthritis, 1096
- Hormones, as risk factors in the development of SLE, 1714
- Hprt gene, mutant T cells in RA, 1772
- Human cytomegalovirus and vasculopathy of SSc, 10
- Human immunodeficiency virus (HIV)
- hepatitis C virus and arthralgia and cryoglobulinemia in, 740
- hepatitis C virus autoantibodies in, with and without concurrent infection, 2077
- Poncet's disease and papulonecrotic tuberculid in, 1884
- Human T cell leukemia virus type I
- autoantigens of Env/Tax proteins in, 101
- Tax protein activation of synovial cells, 1995
- Human T lymphotropic virus I, in SS, 1972
- Human umbilical vein endothelial cells (HUVEC), VLA/VCAM-1- mediated lymphocyte cell adhesion and NSAIDs, 1677
- HUT-78 cells, induction of matrix metalloproteinase 1 and prostaglandins by, 1748
- Hyaluronan
- adduction moment and disease severity in knee OA and, 1233
- CD44 antisense inhibition of, and cartilage chondrolysis, 1411
- intraarticular, in canine OA, 976
- pseudogout following intraarticular injection of, 939
- 7-hydroxymethotrexate-treated rat adjuvant arthritis, 1407
- 5-hydroxytryptamine, in fibromyalgic muscle tissue, 1689
- Hyperplasia, in giant cell (temporal) arteritis, 623
- Hypertension, pulmonary, prostacyclin in SSc-associated, 466
